Sign in

CIK 0001023024 · Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
582301143
Phone
6097591810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,939,756
in 9 filings, $1.9M under 10b5-1 plans

Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lalwani Nikhil −$1.2M PRESIDENT & CEO sold 5% of stake
  2. CAREY STEPHEN P. −$623K SVP & CFO sold 5% of stake
  3. Cook Meredith −$72K SR. VP, GENERAL COUNSEL & SEC. sold 1% of stake
  4. Thoma Jeanne −$72K Director sold 4% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-07 Marken James G. SVP OPS & PROD DEV Shares withheld for taxes −1,951 $44.23 $86K 115,691
2023-03-07 Marken James G. SVP OPS & PROD DEV Shares withheld for taxes −509 $44.23 $23K 115,182
2023-02-28 CAREY STEPHEN P. SVP & CFO Grant or award +24,316 161,802
2023-02-28 CAREY STEPHEN P. SVP & CFO Grant or award +16,210 178,012
2023-02-28 Lalwani Nikhil PRESIDENT & CEO Grant or award +95,530 346,370
2023-02-28 Lalwani Nikhil PRESIDENT & CEO Grant or award +63,686 410,056
2023-02-28 Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS Grant or award +17,369 35,829
2023-02-28 Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS Grant or award +11,578 47,407
2023-02-28 Mutz Christopher HEAD OF RARE DISEASE Grant or award +17,369 55,029
2023-02-28 Mutz Christopher HEAD OF RARE DISEASE Grant or award +11,578 66,607
2023-02-28 Marken James G. SVP OPS & PROD DEV Grant or award +13,026 125,232
2023-02-28 Marken James G. SVP OPS & PROD DEV Grant or award +8,684 133,916
2023-02-28 Gutwerg Ori SVP, GENERICS Grant or award +17,369 51,396
2023-02-28 Gutwerg Ori SVP, GENERICS Grant or award +11,578 62,974
2023-02-28 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +17,369 17,369
2023-02-28 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +11,578 28,947
2023-02-28 Davis Krista SVP, CHIEF HR OFFICER Grant or award +12,158 28,591
2023-02-28 Davis Krista SVP, CHIEF HR OFFICER Grant or award +8,104 36,695
2023-02-28 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Grant or award +12,158 31,438
2023-02-28 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Grant or award +8,104 39,542

Page 21 of 23 · 442 trades